Berlin, Germany

Gunter Neef



Average Co-Inventor Count = 5.6

ph-index = 13

Forward Citations = 431(Granted Patents)

Forward Citations (Not Self Cited) = 405(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1977-2006

Loading Chart...
Loading Chart...
51 patents (USPTO):Explore Patents

Title: Exploring the Inventive Mind of Gunter Neef

Introduction:

Gunter Neef, a prolific inventor based in Berlin, DE, has made significant contributions to the field of pharmaceuticals with a total of 51 patents to his name. His innovative work has focused on developing new compounds with unique properties for the production of pharmaceutical preparations.

Latest Patents:

1. Antigestagenically active steroids with a fluorinated 17α-alkyl chain: In this invention, Gunter Neef describes novel 17α-fluoroalkyl steroids with strong antigestagenic action, suitable for pharmaceutical applications.

2. Vitamin D derivatives with cyclopropyl rings in the lateral chains: Neef's invention revolves around new vitamin D derivatives, their production method, intermediate products, and their utility in medicament production.

Career Highlights:

Throughout his career, Gunter Neef has worked with esteemed companies such as Schering Aktiengesellschaft and A/S Ferrosan. His tenure at these organizations has undoubtedly influenced his inventive spirit and enriched his knowledge base in the pharmaceutical industry.

Collaborations:

Neef's collaborative efforts with coworkers like Rudolf Wiechert and Walter Elger have further fueled his innovative endeavors. The exchange of ideas and expertise among these professionals has undoubtedly played a pivotal role in the success of his inventions.

Conclusion:

In conclusion, Gunter Neef stands as a shining example of a visionary inventor in the pharmaceutical sector. His groundbreaking patents and fruitful collaborations underscore his commitment to advancing scientific knowledge and pushing the boundaries of pharmaceutical innovation in Berlin and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…